Genmab (GMAB)
(Real Time Quote from BATS)
$28.04 USD
-0.04 (-0.14%)
Updated Sep 18, 2025 03:36 PM ET
3-Hold of 5 3
B Value D Growth B Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Genmab A/S Sponsored ADR has a market cap of $18.02B, which represents its share price of $28.08 multiplied by its outstanding shares number of 641.59M. As a large-cap company, GMAB's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
GMAB 28.04 -0.04(-0.14%)
Will GMAB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GMAB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GMAB
IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi
Wall Street Analysts Believe Genmab (GMAB) Could Rally 33.8%: Here's is How to Trade
GMAB: What are Zacks experts saying now?
Zacks Private Portfolio Services
NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View
Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut
JAZZ Stock Down on Wider-Than-Expected Q2 Loss, '25 Sales View Cut
Other News for GMAB
GMAB's price falls by 0.57% on September 17, though its technical setup remains stable.
GMAB forms NR7 on September 16
GMAB forms Pocket Pivot on September 15
Genmab Transitioning To A Global Oncology Powerhouse: Why I Choose To Buy
Is GMAB likely to continue higher? Slingshot Bullish shows up after slipping 2.76%